Tumor Microenvironment
Tumor Microenvironment(肿瘤微环境)
Tumor Microenvironment 相关产品(42)
- GC409472,3-Dimethoxy-5-methyl-p-benzoquinoneCAS: 605-94-7纯度: >98.00%
An intermediate in the synthesis of ubiquinones that has anticancer activity
- GC413105-Octyl-α-ketoglutarateCAS: 1616344-00-3纯度: >98.00%
A cell-permeable form of α-ketoglutarate
- GC43727Ganglioside GD1a mixture (sodium salt)CAS: 12707-58-3纯度: >98.00%
A mixture of ganglioside G D1a
- GC47297EP4 Receptor Antagonist 1CAS: 2287259-07-6纯度: >98.00%
EP4 receptor antagonist 1前列腺素E2受体EP4亚型的高效选择性拮抗剂，对人和小鼠EP4受体的半抑制浓度（IC₅₀）分别为6.1nM和16.2nM。
- GC47965Pomalidomide-d5CAS: 1377838-49-7纯度: >99.00%
An internal standard for the quantification of pomalidomide
- GC48335N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)CAS: 69345-49-9纯度: >98.00%
A mixture of N-glycolyl-ganglioside G M3
- GC489432-deoxy-2-fluoro-D-GlucoseCAS: 29702-43-0纯度: >98.00%
A glucose derivative with anticancer activity
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC15594 | PX 12 | 141400-58-0 | >98.00% | |
An irreversible inhibitor of thioredoxin-1 | ||||
| GC18449 | Cardanol monoene | 501-26-8 | - | |
An inhibitor of tyrosinase with anticancer properties | ||||
| GC18787 | (±)-Dunnione | 521-49-3 | - | |
A naphthoquinone with diverse biological activities | ||||
| GC40555 | Tiopronin | 1953-02-2 | >98.00% | |
Tiopronin is an antioxidant that has diverse biological activities. | ||||
| GC40947 | 2,3-Dimethoxy-5-methyl-p-benzoquinone | 605-94-7 | >98.00% | |
An intermediate in the synthesis of ubiquinones that has anticancer activity | ||||
| GC41310 | 5-Octyl-α-ketoglutarate | 1616344-00-3 | >98.00% | |
A cell-permeable form of α-ketoglutarate | ||||
| GC41342 | Terrecyclic Acid | 83058-94-0 | >95.00% | |
A sesquiterpene | ||||
| GC41572 | PRLX-93936 | 903499-49-0 | >98.00% | |
An erastin analog with antitumor activity | ||||
| GC41642 | 9(E),11(E),13(E)-Octadecatrienoic Acid | 544-73-0 | >97.00% | |
A polyunsaturated fatty acid | ||||
| GC41645 | Jacaric Acid | 28872-28-8 | >95.00% | |
A conjugated PUFA | ||||
| GC43204 | CAY10730 | 2206677-06-5 | >98.00% | |
A turn-on fluorescent probe to detect hypoxia | ||||
| GC43361 | Cytostatin (sodium salt) | 457070-06-3 | >75.00% | |
A selective PP2A inhibitor | ||||
| GC43565 | Doxorubicinol (hydrochloride) | 63950-05-0 | >90.00% | |
A doxorubicin metabolite | ||||
| GC43727 | Ganglioside GD1a mixture (sodium salt) | 12707-58-3 | >98.00% | |
A mixture of ganglioside G D1a | ||||
| GC45404 | CAY10736 | 2251753-61-2 | >90.00% | |
An anticancer compound | ||||
| GC45798 | Rhein-13C4 | 1189928-10-6 | >95.00% | |
An internal standard for the quantification of rhein | ||||
| GC46031 | Malabaricone B | 63335-24-0 | >98.00% | |
A diarylnonanoid with diverse biological activities | ||||
| GC47137 | Cy5-SE (triethylamine salt) | 1497420-70-8 | >95.00% | |
An amine-reactive fluorescent probe | ||||
| GC47297 | EP4 Receptor Antagonist 1 | 2287259-07-6 | >98.00% | |
EP4 receptor antagonist 1前列腺素E2受体EP4亚型的高效选择性拮抗剂，对人和小鼠EP4受体的半抑制浓度（IC₅₀）分别为6.1nM和16.2nM。 | ||||
| GC47965 | Pomalidomide-d5 | 1377838-49-7 | >99.00% | |
An internal standard for the quantification of pomalidomide | ||||
| GC48335 | N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) | 69345-49-9 | >98.00% | |
A mixture of N-glycolyl-ganglioside G M3 | ||||
| GC48493 | PCI 45227 | 1654820-87-7 | >99.50% | |
An active metabolite of ibrutinib | ||||
| GC48943 | 2-deoxy-2-fluoro-D-Glucose | 29702-43-0 | >98.00% | |
A glucose derivative with anticancer activity | ||||
| GC48989 | LTX-315 (trifluoroacetate salt) | - | >95.00% | |
A synthetic cationic amphiphilic peptide | ||||